PolyPid News
News
0
Ticker
PYPD
ISIN
IL0011326795
PolyPid Eulerpool News
PolyPid Stock News
PolyPid is being monitored by journalists and investors worldwide. We gather the latest PolyPid news here.
- February 11·SeekingAlpha
- February 11·Benzinga
- February 11·ChartMill
- February 11·Benzinga
- February 11·Benzinga
- February 10·Benzinga
- December 10·SeekingAlpha
- November 13·Benzinga
- November 12·Yahoo
- November 12·SeekingAlpha
- September 3·Yahoo
- July 15·Benzinga
- July 15·Yahoo
- June 22·Yahoo
- June 16·Yahoo
- June 9·Benzinga
- June 6·Yahoo
- June 5·Benzinga
- May 15·Yahoo
- May 14·SeekingAlpha
PolyPid Stock Press Releases
PolyPid regularly publishes news on the company's website that are relevant for investors.
- August 10•PolyPid
- August 3•PolyPid
- July 27•PolyPid
- July 25•PolyPid
- July 5•PolyPid
- June 15•PolyPid
- June 6•PolyPid
- June 2•PolyPid
- June 1•PolyPid
- May 31•PolyPid
- May 23•PolyPid
- May 11•PolyPid
- April 27•PolyPid
- April 25•PolyPid
- April 12•PolyPid
- April 6•PolyPid
- March 8•PolyPid
- March 2•PolyPid
- March 1•PolyPid
- February 9•PolyPid
- January 26•PolyPid
- January 4•PolyPid
- January 3•PolyPid
- November 18•PolyPid
- November 16•PolyPid
- November 10•PolyPid
- November 1•PolyPid
- September 20•PolyPid
- September 13•PolyPid
- August 17•PolyPid
PolyPid News 2026
This page contains all current news, analysis and press releases for PolyPid stock (PYPD, ISIN: IL0011326795). This includes Eulerpool news, company analysis and official press releases. Data is updated regularly to provide investors with a complete overview of the latest developments at PolyPid.
PolyPid Stock
PolyPid PolyPid Ltd is an innovative, emerging company in the field of biomedical technology based in Israel. The company was founded in 2008 and has since gained continuous recognition and growth. PolyPid's core business is the development and manufacturing of implantable polymer systems that contribute to wound healing. These polymer systems are specifically introduced into the affected area of the body and continuously release active substances to prevent infections and promote natural healing processes. PolyPid's business model is focused on effectively solving patients' problems. The company has developed a wide range of products and technologies that specifically target various medical applications. These include orthopedics, traumatology, urology, and gynecology. For orthopedics, PolyPid provides various products and technologies that can be used in knee and hip joint surgeries. These include antibiotic-releasing implants to prevent infections and resorbable bone fillers that allow for faster and more effective wound healing. In the field of traumatology, PolyPid manufactures polymer systems that are used in the treatment of bone fractures or other traumas. Here again, the polymer systems ensure continuous release of active substances to prevent infections and promote natural healing processes. PolyPid also offers innovative solutions for urology. Specifically, products are developed to combat urinary tract infections and promote faster wound healing after urological surgeries. For gynecology, PolyPid offers polymer systems that can be used particularly in the postoperative phase to prevent infections and achieve faster wound healing. PolyPid has earned an excellent reputation in the industry in recent years due to its consistent focus on innovation and quality. To continually improve their products, the company invests heavily in research and development and maintains close contact with medical institutions and professionals worldwide. PolyPid is an important partner in the field of biomedical technology and has already received numerous awards for its groundbreaking products and developments. Thanks to its focus on quality, reliability, and innovation, the company will continue to play a key role in the biomedical technology market.